COVID-19 has accelerated the use of home dialysis, says GlobalData

The trend toward utilizing home care for dialysis patients has been occurring for several years and the COVID-19 crisis has accelerated the rate of adoption. The renal dialysis machines market grew by 8% in 2020 and is projected to reach $2.7bn by 2030, according to GlobalData, a leading data and analytics company, with the home dialysis market expected to contribute towards this growth.

Aliyah Farouk, Senior Medical Devices Analyst at GlobalData, comments: “There is an inherent need for more at-home care solutions, presenting an opportunity for dialysis equipment players to join this market. Dialysis patients typically have multiple medical comorbid conditions, including diabetes and obesity, which increase their risk for poor outcomes if they develop COVID-19. Additionally, home dialysis is cost efficient and has better health outcomes.”

Fresenius’ recent partnership with DaVita Health indicates that the shift from outpatient care to home dialysis will be a permanent fixture, even after the pandemic subsides. The company currently leads the renal dialysis machines market with 43% of the market share.

Farouk continues: “Patient demographics, reimbursement policies and physician hesitation have previously restricted the broader use of home dialysis. However, the marketed is expected to still exhibit strong growth due to the increased demand.”

More Media